Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01130 |
| Species: | Homo sapiens |
| Position : | chr10:51546800-51547317 |
| Year: | 2016 |
| Title: | Chromatin interactions and candidate genes at ten prostate cancer risk loci |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 26979803 |
| MONDO: | MONDO:0008315 |
| Tissue: | Prostate |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | LNCaP |
| CVCL ID: | CVCL_0395 |
| Cell Type: | prostate carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay, TF binding assay |
| High Throughput Method: | Capture 3C-seq, ChIP-seq, RNA-seq, SNP genotyping array |
| Low Throughput Method: | Luciferase reporter assay, Site-directed mutagenesis, 3C-qPCR, RT-qPCR |
| Target gene : | ANTXRLP1 |
| TF name : | AR; FOXA1; HOXB13; CTCF |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|